Why mental health practitioners resist AI documentation tools

Mental health practitioners report distinctive hesitation toward AI documentation tools, and the reasons are more substantive than simple technophobia, though the evidence for how this compares with other specialties is limited and largely self-reported rather than based on a direct cross-specialty study. The therapeutic relationship in mental health is not just the context for care, it is the mechanism of care. That distinction shapes how practitioners think about documentation, consent, data, and clinical judgment in ways that AI tool developers and practice managers are only beginning to grapple with seriously.

What the data shows: documentation reluctance across specialties

The pattern of higher reluctance in mental health settings appears across multiple recent sources, though the evidence base remains developing rather than definitive. A 2025 American Psychological Association Practitioner Pulse Survey of 1,742 psychologists found that while 56 per cent had used AI at least once, 38 per cent worried that AI might make some or all of their job duties obsolete. No directly comparable primary-care survey was identified for this figure, so the scale of the difference with other specialties remains unclear. A cross-sectional study published in Frontiers in Psychiatry cited other research finding that nearly half (48.2%) of healthcare professionals generally exhibit poor digital literacy, and noted that other literature on healthcare professionals more broadly has raised job security, ethical and moral dilemmas, and impact on patient-provider relationships as barriers to AI uptake.

A European-authored case series from Croatia found that psychiatrist resistance to AI tools stemmed from ethical dilemmas, trust deficits, and institutional factors rather than technophobia. A scoping review published in Discover Public Health covering studies up to March 2025 identified clinician resistance stemming from concerns about autonomy and the ethical implications of AI-supported clinical decisions as a major barrier in psychiatric AI implementation broadly (not specific to documentation).

The evidence base is uneven. Most available studies are small-scale, qualitative, or based on self-reported attitudes rather than observed behaviour at scale. The picture is consistent in direction but should not be overstated.

The therapeutic alliance problem: why AI feels different in a therapy room

In most clinical specialties, the encounter between clinician and patient is the vehicle for delivering care; a diagnosis, a prescription, a procedure. In mental health practice, the relationship itself is often the primary therapeutic instrument. Therapeutic alliance, meaning the quality of the collaborative bond between therapist and patient, is widely established in the psychotherapy research literature as one of the most robust predictors of treatment outcome across psychotherapeutic modalities. Anything that alters the relational dynamic is therefore not merely a workflow consideration but a clinical one.

This is why mental health practitioners evaluate the introduction of an AI assistant differently from how a general practitioner (GP) might. A GP using ambient voice technology (AVT), which captures and transcribes speech during a consultation, to reduce note-taking is freeing up attention for the patient. A therapist using the same tool may be introducing a third presence into a space where the dyadic relationship is the treatment. A simulation study of psychiatrists using AI scribes found that clinicians adapted their verbal behaviour for the system, for example by narrating non-verbal cues aloud — a strategy the study's participants generally described as a useful optimisation rather than a disruption, though it does illustrate how the presence of the tool shapes clinician behaviour during the consultation.

Practitioner-facing reporting has captured this concern in direct language. One practitioner quoted in Behavioral Health Business described the therapeutic space as a "sacred process" incompatible with ambient surveillance, and noted that AI scribes "inherently break confidentiality" in therapy. Whether or not one agrees with that framing, it reflects a clinically grounded concern about the conditions under which therapeutic work is possible.

Patient trust and disclosure: what practitioners fear AI presence will change

A related but distinct concern involves patient behaviour, not just clinician behaviour. Mental health practitioners report worrying that patients who know a session is being recorded or transcribed, even by a tool framed as secure and private, may self-censor sensitive disclosures. The content most at risk includes disclosures around trauma, sexuality, suicidality, substance use, and experiences of abuse: precisely the material that is most clinically important and most difficult for patients to share.

This concern has some empirical grounding. A recent NPR investigation reported findings on American trust in AI for mental health care, and that therapists navigating AI note-taking tools must manage significant patient anxiety around consent and data use. A dedicated report developed with National Health Service (NHS) mental health professionals and patients identified particular vulnerability among patients with paranoia or trauma histories, for whom the presence of an AI scribe may carry specific clinical risk beyond general privacy concern.

The Frontiers in Psychiatry qualitative study also identified a live tension between retaining session recordings as a backup against data loss versus minimizing or deleting them to reduce privacy and confidentiality risks — notably, that study's overall findings about AI scribes were largely positive.

The language problem: why psychological nuance is harder to capture

Mental health practitioners raise a further concern specific to the content of clinical documentation in their field: that AI-generated notes may fail to accurately represent what happened in a session, not because the transcription is inaccurate but because the clinically meaningful content of a therapy session is not straightforwardly verbal.

The challenges include:

• Tonal ambiguity: A patient saying "I'm fine" may be communicating distress. The literal transcription is accurate; the clinical meaning is the opposite.

• Metaphorical language: Patients frequently use metaphor, narrative, and indirect expression when approaching difficult material. AI systems trained on clinical language may flatten or misread this.

• Silence and non-verbal cues: A significant pause, a change in posture, or a patient's visible emotional response may be the most clinically important moment in a session, and entirely absent from any transcript.

• The gap between reported and observed: What a patient says and what a clinician clinically observes are often different, and the latter is the basis for formulation and treatment planning.

Mental health encounters are often described as "complex, exploratory, and relational" in ways that distinguish them from the structured information-gathering of a physical examination. Research on AI ambient scribes in primary care has raised questions about whether greater levels of neuropsychiatric symptom documentation translates into better clinical management, or whether something is lost in the translation from session to structured record.

Confidentiality, consent, and GDPR: heightened sensitivity in mental health records

Mental health records occupy a distinct position in data protection law. Under the General Data Protection Regulation (GDPR), data concerning mental health is classified as special category data, attracting the highest level of protection and the most stringent requirements for lawful processing. For European practitioners, this creates specific GDPR obligations that go beyond the general data security questions that apply to AI tools in other clinical contexts.

The questions practitioners are asking, and that AI tool developers are not always equipped to answer clearly, include:

• Where is session content processed and stored? Is data residency within the European Union (EU) guaranteed?

• What happens to transcripts or derived summaries after note generation? Are they retained, and by whom?

• Does the AI vendor's processing constitute a separate lawful basis, or does patient consent to treatment extend to AI-assisted documentation?

• What are the obligations if a data subject requests deletion of records that include AI-processed session content?

A practitioner-facing article in Digital Health noted that NHS mental health professionals raised these questions explicitly in the context of ambient scribe deployment. A US vendor-published analysis of ambient AI scribes has separately raised the concern that permanent transcripts of therapy sessions could create greater discovery/subpoena exposure than handwritten or typed notes, since a verbatim record differs from a clinical summary — a legal concept drawn from US malpractice practice, whose applicability to European legal systems has not been independently verified.

The IEACP ethical framework published in Psychological Medicine, developed through synthesis of multiple studies, identifies privacy and transparency as core ethical values in computational psychiatry. It argues that structured ethical decision-making processes are necessary precisely because existing AI guidelines do not adequately address the specific conditions of mental health practice.

Professional identity and clinical judgment: when documentation is part of the process

There is a further dimension to mental health practitioners' reluctance that technology adoption literature less frequently acknowledges: for many therapists and psychologists, writing clinical notes is not administrative overhead. It is a reflective clinical act.

The process of formulating a session in writing, deciding what to record, how to characterise a patient's presentation, and what to name a clinical observation, is part of how practitioners process, make sense of, and plan around a session. This is particularly true in psychodynamic, psychoanalytic, and systemic traditions, where the clinician's own reflective process is considered part of the therapeutic work. Handing that process to an AI assistant does not feel like relief from documentation burden; it feels like a displacement of clinical reasoning.

This framing is consistent with the broader concern that mental health professionals worry about AI eroding clinical judgment, not just practical barriers like digital literacy or data security. The IEACP framework explicitly identifies "erosion of clinical judgment" as one of the core risks requiring ethical governance in computational psychiatry.

A practical review in Molecular Psychiatry notes that AI's clinical adoption in psychiatry "remains limited" despite its technical potential, and advocates for a "judicious integration" that maintains "the human-centric essence of psychiatric practice," acknowledging that the technology and the clinical culture are not yet well aligned.

What practitioners say they would need before adopting AI documentation tools

Across the sources reviewed, mental health practitioners articulate a reasonably consistent set of prerequisites for adoption. These are not demands for perfection but conditions for clinical confidence:

• Patient consent frameworks: Explicit, session-level informed consent to AI-assisted documentation, separate from general consent to treatment. Not a checkbox in a registration form, but a conversation.

• Session-level opt-in controls: The ability for either the clinician or the patient to exclude specific sessions or disclosures from AI processing, particularly relevant for high-sensitivity material.

• Transparency about data processing: Clear, accessible information about where data is processed, how long it is retained, who can access it, and under what legal basis.

• Meaningful editability: Confidence that AI-generated notes can be substantially edited before they enter the clinical record, and that the clinician, not the AI output, is the authoritative source.

• Mental health-specific validation: Evidence that tools have been tested and validated in mental health contexts, not simply adapted from primary care or hospital medicine workflows.

The APA Monitor reporting notes that hesitation around AI in therapy mirrors early resistance to medical record systems, and suggests that education and peer processing were key to adoption. This suggests the pathway to adoption is social and professional as well as technical. Research among psychiatric staff has found that providing basic information about how machine learning-based clinical decision support systems work can increase trust and reduce distrust, a finding with direct implications for how AI tools should be introduced in mental health settings.

Implications for practice managers and clinical leads planning AI rollouts

For those responsible for deploying AI documentation tools in mental health settings, the practitioner concerns above translate into concrete planning considerations:

• Co-design, not consultation: Practitioners who have been involved in shaping a tool's implementation, including its consent processes, opt-out mechanisms, and documentation templates, are more likely to use it and less likely to experience it as an imposition.

• Pilot in lower-acuity contexts first: Starting with administrative tasks such as discharge summaries, referral letters, and between-session correspondence, rather than session transcription, lets practitioners build familiarity with AI-assisted documentation without immediately confronting the therapeutic alliance question.

• Treat reluctance as clinical feedback: The Discover Public Health scoping review frames clinician resistance as a major implementation barrier, but the same literature makes clear that this resistance encodes legitimate clinical concerns. Practice managers who treat it as change resistance to be managed will encounter more of it; those who treat it as information will learn from it.

• Provide clear data governance documentation: Given GDPR obligations and the special category status of mental health data, practitioners need written assurance, not verbal reassurance, about data residency, retention, and access controls before they can responsibly use AI documentation tools with their patients.

• Create space for peer processing: Reporting on AI adoption in therapy suggests that peer discussion, not just product demonstrations, plays an important role in building practitioner comfort with new tools, though the evidence for this specific mechanism remains limited.

Reluctance as signal, not obstacle

The higher documentation reluctance reported by mental health practitioners is not a failure of digital literacy or an irrational attachment to existing workflows. It reflects the specific clinical and ethical demands of work in which the relationship is the treatment, the language is the data, and the records are among the most sensitive documents in healthcare. When practitioners raise concerns about therapeutic alliance, patient disclosure, GDPR compliance, and the reflective function of note-writing, they are describing real clinical risks, risks that are more acute in mental health than in most other specialties.

The World Psychiatry review of digital mental health implementation concludes that digital tools "can positively impact mental health care if deployed correctly," with "correctly" doing significant work in that sentence. Correct deployment in mental health requires engagement with the concerns documented here, not workarounds for them. AI tool developers and practice leaders who take that seriously are better positioned to build tools, and the clinical trust, that actually function in this environment.

Frequently asked questions

▶ Why are mental health practitioners more reluctant to use AI documentation tools than other clinicians?

Mental health practitioners report higher hesitation toward AI-assisted clinical documentation than colleagues in primary care, physiotherapy, or hospital medicine. Research points to three main reasons: concerns about the therapeutic relationship, ethical and data privacy dilemmas, and questions about clinical judgment. In mental health practice, the relationship between clinician and patient is itself the primary mechanism of care, not simply the context for it. That distinction makes the introduction of any AI assistant a clinical question, not just a workflow one.

▶ What does the evidence say about AI adoption in mental health settings?

The evidence base is developing rather than definitive. A 2025 American Psychological Association Practitioner Pulse Survey of 1,742 psychologists found that 56 per cent had used AI at least once, but 38 per cent worried it might make some or all of their job duties obsolete. A cross-sectional study published in Frontiers in Psychiatry cited other research on healthcare professionals generally finding that nearly half (48.2%) exhibit poor digital literacy, and noted ethical dilemmas, patient-provider relationship concerns, and job security as barriers raised in the broader literature. A scoping review published in Discover Public Health identified clinician resistance stemming from concerns about autonomy and the ethical implications of AI-supported clinical decisions as a major barrier to psychiatric AI implementation broadly.

▶ How does ambient voice technology affect the therapeutic relationship in mental health sessions?

Therapeutic alliance, the quality of the collaborative bond between therapist and patient, is one of the most robust predictors of treatment outcome across psychotherapeutic modalities. A general practitioner using ambient voice technology to reduce note-taking frees up attention for the patient. A therapist using the same tool may be introducing a third presence into a space where the dyadic relationship is the treatment. A simulation study of psychiatrists using AI scribes found that clinicians adapted their verbal behaviour for the system, for example by narrating non-verbal cues aloud — a strategy the study's participants generally described as a useful optimisation rather than a disruption, though it does illustrate how the presence of the tool shapes clinician behaviour during the consultation.

▶ Could AI documentation tools affect what patients are willing to disclose in therapy?

Mental health practitioners report worrying that patients who know a session is being recorded or transcribed may self-censor sensitive disclosures. The content most at risk includes disclosures around trauma, sexuality, suicidality, substance use, and experiences of abuse. A report developed with National Health Service mental health professionals and patients identified particular vulnerability among patients with paranoia or trauma histories, for whom the presence of an AI scribe may carry specific clinical risk beyond general privacy concern. A recent NPR investigation also reported that therapists navigating AI note-taking tools must manage significant patient anxiety around consent and data use.

▶ Why is AI-generated documentation harder to get right in mental health than in other specialties?

The clinically meaningful content of a therapy session is not straightforwardly verbal. A patient saying "I'm fine" may be communicating distress. The literal transcription is accurate; the clinical meaning is the opposite. Patients frequently use metaphor and indirect expression when approaching difficult material, and AI systems trained on clinical language may flatten or misread this. Silence, changes in posture, and visible emotional responses may be the most clinically important moments in a session, yet they are entirely absent from any transcript. Mental health encounters are often described as "complex, exploratory, and relational" in ways that distinguish them from the structured information-gathering of a physical examination.

▶ What are the GDPR obligations for AI documentation tools used in mental health practice?

Under the General Data Protection Regulation, data concerning mental health is classified as special category data, attracting the highest level of protection and the most stringent requirements for lawful processing. European practitioners need clear answers to several questions before using AI documentation tools: where session content is processed and stored, whether data residency within the European Union is guaranteed, what happens to transcripts after note generation, and what the legal basis is for the AI vendor's processing. A US vendor-published analysis has also raised the concern that permanent transcripts of therapy sessions could create greater discovery exposure than handwritten or typed clinical notes, since a verbatim record differs from a clinical summary — though this is a US legal concept whose applicability in European jurisdictions is untested.

▶ Is writing clinical notes considered an administrative task or a clinical act in mental health practice?

For many therapists and psychologists, writing clinical notes is a reflective clinical act rather than administrative overhead. The process of formulating a session in writing, deciding what to record and how to characterise a patient's presentation, is part of how practitioners process and plan around a session. This is particularly true in psychodynamic, psychoanalytic, and systemic traditions, where the clinician's own reflective process is considered part of the therapeutic work. The IEACP ethical framework published in Psychological Medicine explicitly identifies erosion of clinical judgment as one of the core risks requiring ethical governance in computational psychiatry.

▶ What conditions do mental health practitioners say they need before adopting AI documentation tools?

Across the sources reviewed, practitioners articulate a consistent set of prerequisites. They want explicit, session-level informed consent to AI-assisted documentation, separate from general consent to treatment. They want session-level opt-in controls so that either the clinician or the patient can exclude specific sessions or disclosures from AI processing. They want transparent information about data processing, retention, and access. They want confidence that AI-generated notes can be substantially edited before entering the clinical record. And they want evidence that tools have been tested and validated in mental health contexts specifically, not simply adapted from primary care or hospital medicine workflows.

▶ What should practice managers consider when planning an AI documentation rollout in mental health settings?

The article identifies several concrete planning considerations. Co-designing implementation with practitioners, including consent processes, opt-out mechanisms, and documentation templates, increases uptake and reduces resistance. Starting with administrative tasks such as discharge summaries and referral letters, rather than session transcription, lets practitioners build familiarity without immediately confronting the therapeutic alliance question. Practitioners need written assurance about data residency, retention, and access controls, not verbal reassurance. Creating space for peer discussion is also likely to help: available reporting suggests peer discussion plays a meaningful role in building practitioner comfort with new tools, alongside product demonstrations.

▶ Does clinician reluctance toward AI documentation tools in mental health reflect a failure of digital literacy?

The evidence does not support that framing. A European-authored case series from Croatia found that psychiatrist resistance stemmed from ethical dilemmas, trust deficits, and institutional factors rather than technophobia. The IEACP ethical framework and related literature describe concerns that extend beyond practical barriers like digital literacy to questions about the erosion of clinical judgment. The Discover Public Health scoping review frames clinician resistance as encoding legitimate clinical concerns. A review in Molecular Psychiatry advocates for a "judicious integration" that maintains "the human-centric essence of psychiatric practice," acknowledging that the technology and the clinical culture are not yet well aligned.